Cambridge University Hospitals

Cambridge CB2 0QQ

2 studies enrolling now · 5 studies all time

What they study most

Angelman Syndrome, Atherosclerosis of Extremities, Breast Cancer, Inflammation, Peripheral Arterial Disease, Pompe Disease (Late-onset), Staphylococcus Aureus Bacteremia

Studies at this site

• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk — Recruiting now
• A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome — Completed
• A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed
• The OPBC-07/microNAC Study — Running, not enrolling